A citation-based method for searching scientific literature

Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
Times Cited: 1022







List of co-cited articles
109 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
21

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
16

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
12

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
11

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
11

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
10

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
9

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
8

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
8

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
8

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
8

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
7


GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
6

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
6

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
4

GRADE guidelines: 7. Rating the quality of evidence--inconsistency.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Paul Glasziou, Roman Jaeschke, Elie A Akl,[...]. J Clin Epidemiol 2011
4

GRADE guidelines: 9. Rating up the quality of evidence.
Gordon H Guyatt, Andrew D Oxman, Shahnaz Sultan, Paul Glasziou, Elie A Akl, Pablo Alonso-Coello, David Atkins, Regina Kunz, Jan Brozek, Victor Montori,[...]. J Clin Epidemiol 2011
647
4

Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-Jie Guan, Zheng-Yi Ni, Yu Hu, Wen-Hua Liang, Chun-Quan Ou, Jian-Xing He, Lei Liu, Hong Shan, Chun-Liang Lei, David S C Hui,[...]. N Engl J Med 2020
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
4

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
3

How to perform a meta-analysis with R: a practical tutorial.
Sara Balduzzi, Gerta Rücker, Guido Schwarzer. Evid Based Ment Health 2019
538
3

GRADE guidelines 6. Rating the quality of evidence--imprecision.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist,[...]. J Clin Epidemiol 2011
3

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
3

GRADE guidelines: 5. Rating the quality of evidence--publication bias.
Gordon H Guyatt, Andrew D Oxman, Victor Montori, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Ben Djulbegovic, David Atkins, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
878
3

The skills and experience of GRADE methodologists can be assessed with a simple tool.
Susan L Norris, Joerg J Meerpohl, Elie A Akl, Holger J Schünemann, Gerald Gartlehner, Yaolong Chen, Craig Whittington. J Clin Epidemiol 2016
86
3

GRADE guidelines: 8. Rating the quality of evidence--indirectness.
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, James Woodcock, Jan Brozek, Mark Helfand, Pablo Alonso-Coello, Yngve Falck-Ytter, Roman Jaeschke, Gunn Vist,[...]. J Clin Epidemiol 2011
846
3


Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
3

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
3

Meta-analysis in clinical trials revisited.
Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
983
3

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
3

Characteristics of COVID-19 infection in Beijing.
Sijia Tian, Nan Hu, Jing Lou, Kun Chen, Xuqin Kang, Zhenjun Xiang, Hui Chen, Dali Wang, Ning Liu, Dong Liu,[...]. J Infect 2020
499
3


Reliability and validity of the subjective component of the American Orthopaedic Foot and Ankle Society clinical rating scales.
Talal Ibrahim, Almoghera Beiri, Mohamed Azzabi, Alistair J Best, Grahame J Taylor, Dipen K Menon. J Foot Ankle Surg 2007
400
3

PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement.
Jessie McGowan, Margaret Sampson, Douglas M Salzwedel, Elise Cogo, Vicki Foerster, Carol Lefebvre. J Clin Epidemiol 2016
949
3

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
Milo A Puhan, Holger J Schünemann, Mohammad Hassan Murad, Tianjing Li, Romina Brignardello-Petersen, Jasvinder A Singh, Alfons G Kessels, Gordon H Guyatt. BMJ 2014
710
3


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
3

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
3

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
3

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
2



CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
David Moher, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, P J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman. BMJ 2010
2



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.